Objectives: To test CIDP patients for IgG positivity towards NF155, NF186 and NF140.
Samples:
CODE | RESULT NF155 | RESULT NF140 | RESULT NF186 |
---|---|---|---|
0 | - | - | - |
1 | - | - | - |
2 | - | - | - |
3 | - | - | - |
4 | + | - | - |
5 | - | - | - |
6 | - | - | - |
7 | - | - | - |
8 | - | - | - |
9 | - | - | - |
10 | - | - | - |
11 | - | - | - |
12 | - | - | - |
13 | - | - | - |
14 | - | - | - |
15 | - | - | - |
16 | - | - | - |
17 | + | - | - |
18 | - | - | - |
19 | - | - | - |
20 | - | - | - |
21 | - | - | - |
22 | - | - | - |
CTRL + (15-195) | + | + | - |
CTRL - | - | - | - |
NF155, NF186, NF140 ICC:
- HEKs 293 Cells Transfection: 2018.07.26
- Blocking solution: 5% goat serum in PBS.
- Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
- Primary antibody: AF3235 diluted 1/1000.
- Secondary antibodies:
- For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
- Vectashield mounting medium.
Results: Samples 4 and 17 were positive for IgG towards NF155. The rest of samples were negative.